Heggie
Andrew Heggie, Canon City, CO US
Patent application number | Description | Published |
---|---|---|
20160028183 | WATER BONDING DEVICE AND METHODS OF USE - A water bonding device for electrically grounding a swimming pool is described. Embodiments include a bonding electrode installed in a pool skimmer or pump strainer. The bonding electrode typically resides in a skimmer or strainer cavity, and a ground conductor coupled directly to the electrode extends out of the skimmer or strainer through a port. A plug assembly forms a water tight seal against the port and the ground conductor, providing a water tight access point for the ground conductor to enter the pool skimmer or pump strainer. The ground conductor is typically electrically connected to both the bonding electrode and a ground pole residing at ground potential. | 01-28-2016 |
Forest Heggie, Lasalle CA
Patent application number | Description | Published |
---|---|---|
20160123198 | ENGINE WITH EXTERNAL CAM LUBRICATION - An engine, such as a variable displacement engine, has a camshaft retainer. The camshaft retainer has a cap adapted to cooperate with a carrier to support first and second overhead camshafts for rotation. The retainer cap forms a housing for a camshaft journal bearing. The retainer cap also forms a retainer land defining an open channel adapted to provide a jet of lubricating fluid from the bearing housing to externally lubricate a cam. The retainer land is adapted to mate with a sealing land of the carrier to enclose the open channel. | 05-05-2016 |
Reginald Heggie, Fredericksburg, VA US
Patent application number | Description | Published |
---|---|---|
20140260941 | Mountable Fixture for Absorbing Recoil - A fixture is provided for supporting load from weapons recoil, being mountable on a flat bed of a road vehicle disposed on ground. The flat bed can receive a weapons mount. The vehicle has longitudinal, lateral and vertical orientations. The fixture includes a box brace, a recoil platform, first and second brackets, first and second beams, first and second posts and a deck. The box brace extends in the lateral direction. The recoil platform is parallel to the brace. The first and second brackets extend from the platform in the longitudinal direction. The beams are disposable parallel to the brace. The beams are translatable in the lateral direction. The first and second posts extend in the vertical direction downward from respective the first and second beams. The deck can receive the weapons mount, and is disposable on the platform and the brackets. The posts are retractable for stowage and extendible for raising the flat bed above the ground. | 09-18-2014 |
Steven James Heggie, Parks Road GB
Patent application number | Description | Published |
---|---|---|
20080280348 | Method for Converting Aloeresin a to Aloesin - The invention provides a process for hydrolytically converting aloeresin A to aloesin by the following reaction: The amount of aloesin available for extraction from sap of aloe plants is thereby increased and the extraction and purification of the aloesin is also made easier and less costly. As aloesin is more commercially valuable than aloeresin A, the process also increases the commercial value of the sap or aloe bitters from the aloe plant. The process optionally also includes the step of separating the aloesin from the p-coumaric acid. Typical hydrolysis steps that are used in the process are acid hydrolysis, base hydrolysis and enzymatic hydrolysis. In the case of acid hydrolysis, the acid is any suitable organic or inorganic acid, such as hydrochloric acid, sulfuric acid, nitric acid or phosphoric acid. In the case of enzymatic hydrolysis, the hydrolytic enzyme is typically an esterase, a lipase or a protease. | 11-13-2008 |
William Heggie, Pamela PT
Patent application number | Description | Published |
---|---|---|
20100286417 | Crystalline Minocycline Base and Processes for its Preparation - The invention provides crystalline minocycline base. In particular, three crystalline polymorphic forms, designated Form I, Form II and Form III, of minocycline base are provided. These are characterised by XRD and IR data. Processes for preparing the new polymorphic forms are also provided. For example, Form I is prepared by dissolving and/or suspending amorphous minocycline base in an organic solvent chosen from ethers followed by crystallisation from the mixture. | 11-11-2010 |
20130030195 | Crystalline Minocycline Base and Processes for its Preparation - The invention provides crystalline minocycline base. In particular, three crystalline polymorphic forms, designated Form I, Form II and Form III, of minocycline base are provided. These are characterised by XRD and IR data. Processes for preparing the new polymorphic forms are also provided. For example, Form I is prepared by dissolving and/or suspending amorphous minocycline base in an organic solvent chosen from ethers followed by crystallisation from the mixture. | 01-31-2013 |
William Heggie, Cabanas PT
Patent application number | Description | Published |
---|---|---|
20100145035 | METHOD OF SYNTHESIZING MACROLIDE COMPOUNDS - The present invention relates to methods for synthesizing macrolide compounds which are known to have antibacterial activity, and are useful in the therapy of bacterial infections in mammals. More specifically, the invention relates to methods for synthesizing the macrolide antibiotic, gamithromycin utilizing a novel configuration of catalysts, chemical structures, and/or methods. An embodiment of the present invention may include allowing multiple chemical reactions to proceed without the isolation of chemical intermediates. Thus, multiple reactions may occur in one reaction vessel allowing for a considerable decrease in the cycle-time. The present invention also provides a novel method for inhibiting degradation while isolating a structure of a pharmaceutical composition. | 06-10-2010 |
20120181201 | Topical Formulation Containing a Tetracycline and a Method of Treating Skin Infections Using the Same - A topical formulation comprising a tetracycline comprises two separate parts: (i) a first part comprising a tetracyline in solid form suspended in a first vehicle; and (ii) a second part comprising a second vehicle in which the tetracycline is soluble. Preferably the tetracycline is crystalline minocycline base. Suitably, a neutral vehicle is used for the first part of the formulation. The two parts of the formulation may be packaged in separate containers and are preferably topically applied therefrom simultaneously. | 07-19-2012 |
William Heggie, Palmela PT
Patent application number | Description | Published |
---|---|---|
20090048463 | Process for the manufacture of iohexol - A process for the production of iohexol comprises alkylating 5-Acetamido-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide using 2(2-methoxy-ethoxy)-ethanol as solvent in the presence of a base, and optionally isolating crude iohexol from the reaction mixture. Preferably, the alkylating agent is 1-chloro-2,3 propanediol and the base is an alkali metal hydroxide such as sodium hydroxide or potassium hydroxide. | 02-19-2009 |
20090215737 | Pharmaceutical Compositions - 2 - The invention provides compositions comprising formula 1 steroids, e.g., 16α-bromo-3β-hydroxy-5α-androstan-17-one hemihydrate and one or more excipients, typically wherein the composition comprises less than about 3% water. The compositions are useful to make improved pharmaceutical formulations. The invention also provides methods of intermittent dosing of steroid compounds such as analogs of 16α-bromo-3β-hydroxy-5α-androstan-17-one and compositions useful in such dosing regimens. The invention further provides compositions and methods to inhibit pathogen (viral) replication, ameliorate symptoms associated with immune dysregulation and to modulate immune responses in a subject using certain steroids and steroid analogs. The invention also provides methods to make and use these immunomodulatory compositions and formulations. | 08-27-2009 |
20100240916 | PROCESS FOR OBTAINING STEROIDAL PHOSPHATE COMPOUNDS - A process for obtaining 21-disodium phosphate pregnane derivative compounds of formula (I), wherein X═R═H or X═F and R=α-CH | 09-23-2010 |
20130072698 | Method and Compounds for the Preparation of Monofluoromethylated Biologically Active Organic Compounds - Described are processes for the preparation of monofluoromethylated organic biologically active compounds, such as Fluticasone Propionate and Fluticasone Furoate, in the presence of fluorodecarboxylating reagents such as XeF | 03-21-2013 |
20130195986 | New Particles of Tetracyclines and Protecting Agent - Particles containing a tetracycline or one of its pharmaceutically acceptable salts and an antioxidant, formulations containing the same and their use in the treatment of infectious diseases are described. Methods of encapsulation of a tetracycline or one of its pharmaceutically acceptable salts and an antioxidant are also disclosed. | 08-01-2013 |
20140155648 | Manufacture of a Triiodinated Contrast Agent - A new compound, (S)-5-(2-acetoxypropanamido)-2,4,6-triiodoisophthalic acid, of formula II (S)-5-(2-acetoxypropanamido)-2,4,6-triiodoisophthalic acid. Said new compound is of use for the production of triiodinated contrast agent, especially lopamidol, with low content of acetyl and hydroxyacetyl analogs. The new compound may be formed from 5-amino-2,4,6-triiodoisophtalic acid by acylating with (S)-1-chloro-1-oxopropan-2-yl acetate. The new compound may then be converted to the respective acid dichloride by reacting with a chlorinating reagent, which is a further object of the present invention, followed by the amidation with 2-amino-1,3-propanediol and acetate hydrolysis. | 06-05-2014 |